pwc glp 1 Rise of GLP-1 weight loss drugs and consumer health: Pill-based GLP-1 medicines set to

Why It Pairs So Well With GLP-1 Agonists GLP-1 agonists like Retatrutide create a caloric deficit through multiple routes: appetite suppression, slowed gastric emptying, and (in Reta's case) glucagon receptor agonism that drives additional energy expenditure

Clinical trials evaluating SGLT2 inhibitors in patients with coronary microvascular dysfunction have shown improvements in coronary flow reserve through mechanisms involving ferroptosis inhibition (86)

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized Phase 2a trial

Contacts for further information References: Wharton S, Lingvay I, Bogdanski P, et al